These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 21391426)

  • 61. Is open surgery for head and neck cancers truly declining?
    Hartl DM; Brasnu DF; Shah JP; Hinni ML; Takes RP; Olsen KD; Kowalski LP; Rodrigo JP; Strojan P; Wolf GT; Rinaldo A; Suárez C; Mendenhall WM; Paleri V; Forastiere AA; Werner JA; Ferlito A
    Eur Arch Otorhinolaryngol; 2013 Nov; 270(11):2793-802. PubMed ID: 23283241
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Pulsed immunosuppression with everolimus and anti-alphabeta T-cell receptor: laryngeal allograft preservation at six months.
    Khariwala SS; Knott PD; Dan O; Klimczak A; Siemionow M; Strome M
    Ann Otol Rhinol Laryngol; 2006 Jan; 115(1):74-80. PubMed ID: 16466103
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Long-term laryngeal allograft survival using low-dose everolimus.
    Lott DG; Dan O; Lu L; Strome M
    Otolaryngol Head Neck Surg; 2010 Jan; 142(1):72-8. PubMed ID: 20096226
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Donor bone marrow in laryngeal transplantation: results of a rat study.
    Khariwala SS; Dan O; Lorenz RR; Klimczak A; Siemionow M; Strome M
    Am J Otolaryngol; 2008; 29(4):242-9. PubMed ID: 18598835
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Evaluation of parathyroid hormone as a functional biological marker of rat laryngeal transplant rejection.
    Nelson M; Dan O; Strome M
    Laryngoscope; 2003 Sep; 113(9):1483-6. PubMed ID: 12972920
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Anti-αβ-T-cell receptor antibodies in the setting of laryngeal transplantation.
    Strome M; Lott DG
    Immunotherapy; 2010 Nov; 2(6):835-45. PubMed ID: 21091115
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Optimizing the immunosuppressive regimen in heart transplantation.
    Eisen H; Ross H
    J Heart Lung Transplant; 2004 May; 23(5 Suppl):S207-13. PubMed ID: 15093807
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Recommendations on the use of everolimus in lung transplantation.
    de Pablo A; Santos F; Solé A; Borro JM; Cifrian JM; Laporta R; Monforte V; Román A; de la Torre M; Ussetti P; Zurbano F
    Transplant Rev (Orlando); 2013 Jan; 27(1):9-16. PubMed ID: 23276646
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Ten-month laryngeal allograft survival with use of pulsed everolimus and anti-alphabeta T-cell receptor antibody immunosuppression.
    Lott DG; Russell JO; Khariwala SS; Dan O; Strome M
    Ann Otol Rhinol Laryngol; 2011 Feb; 120(2):131-6. PubMed ID: 21391426
    [TBL] [Abstract][Full Text] [Related]  

  • 70.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 71.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 72.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 73.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 4.